Compare Abbott India with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA IPCA LABS ABBOTT INDIA/
IPCA LABS
 
P/E (TTM) x 47.2 26.5 177.9% View Chart
P/BV x 14.7 5.3 279.7% View Chart
Dividend Yield % 1.5 0.4 378.4%  

Financials

 ABBOTT INDIA   IPCA LABS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-21
IPCA LABS
Mar-21
ABBOTT INDIA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs18,5692,456 756.2%   
Low Rs13,9701,371 1,018.7%   
Sales per share (Unadj.) Rs2,028.2423.3 479.1%  
Earnings per share (Unadj.) Rs325.090.6 358.9%  
Cash flow per share (Unadj.) Rs352.4107.1 329.2%  
Dividends per share (Unadj.) Rs275.004.00 6,875.0%  
Avg Dividend yield %1.70.2 808.6%  
Book value per share (Unadj.) Rs1,203.7370.6 324.8%  
Shares outstanding (eoy) m21.25126.85 16.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.04.5 177.5%   
Avg P/E ratio x50.121.1 236.9%  
P/CF ratio (eoy) x46.217.9 258.3%  
Price / Book Value ratio x13.55.2 261.8%  
Dividend payout %84.64.4 1,915.6%   
Avg Mkt Cap Rs m345,717242,728 142.4%   
No. of employees `000NANA-   
Total wages/salary Rs m4,92710,136 48.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m43,10053,699 80.3%  
Other income Rs m8351,292 64.6%   
Total revenues Rs m43,93554,991 79.9%   
Gross profit Rs m9,18914,812 62.0%  
Depreciation Rs m5812,092 27.8%   
Interest Rs m183123 149.0%   
Profit before tax Rs m9,26013,890 66.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3532,401 98.0%   
Profit after tax Rs m6,90711,488 60.1%  
Gross profit margin %21.327.6 77.3%  
Effective tax rate %25.417.3 147.0%   
Net profit margin %16.021.4 74.9%  
BALANCE SHEET DATA
Current assets Rs m35,18534,370 102.4%   
Current liabilities Rs m10,30911,331 91.0%   
Net working cap to sales %57.742.9 134.5%  
Current ratio x3.43.0 112.5%  
Inventory Days Days449 9.2%  
Debtors Days Days26 38.4%  
Net fixed assets Rs m3,04126,295 11.6%   
Share capital Rs m213254 83.8%   
"Free" reserves Rs m25,36646,763 54.2%   
Net worth Rs m25,57947,017 54.4%   
Long term debt Rs m0365 0.0%   
Total assets Rs m38,22660,664 63.0%  
Interest coverage x51.7114.2 45.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.9 127.4%   
Return on assets %18.519.1 96.9%  
Return on equity %27.024.4 110.5%  
Return on capital %36.929.6 124.8%  
Exports to sales %0.70-   
Imports to sales %12.30-   
Exports (fob) Rs m295NA-   
Imports (cif) Rs m5,306NA-   
Fx inflow Rs m35327,172 1.3%   
Fx outflow Rs m5,3897,949 67.8%   
Net fx Rs m-5,03519,223 -26.2%   
CASH FLOW
From Operations Rs m7,26710,901 66.7%  
From Investments Rs m-718-5,207 13.8%  
From Financial Activity Rs m-5,818-3,058 190.2%  
Net Cashflow Rs m7312,636 27.7%  

Share Holding

Indian Promoters % 0.0 46.3 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.7 44.0 17.6%  
FIIs % 0.2 11.0 2.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 53.7 46.6%  
Shareholders   90,567 115,335 78.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex, Nifty End Marginally Lower; Metal Stocks Witness Selling(Closing)

After opening on a positive note, Indian share markets failed to keep up early gains and ended the day marginally lower.

Related Views on News

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 23, 2022 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS